Skip to main content

Table 1 Parameters of the consensus beta prior distributions

From: Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis

Beta parameter

Original response criterion

Revised response criterion

 

Adalimumab

α

10.16

15.99

β

5.512

7.123

 

Secukinumab

α

7.13

8.43

β

6.015

5.953

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096